VOYA INVESTMENT MANAGEMENT LLC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 99 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$1,552,519
-78.9%
37,811
-77.7%
0.00%
-75.0%
Q1 2024$7,353,577
+146.1%
169,711
+161.1%
0.01%
+100.0%
Q4 2023$2,987,637
+54.7%
64,991
-22.9%
0.00%
+100.0%
Q3 2023$1,931,637
+39.4%
84,259
+0.3%
0.00%0.0%
Q2 2023$1,385,787
+22.1%
84,038
+32.1%
0.00%
+100.0%
Q1 2023$1,134,534
-38.7%
63,5950.0%0.00%
-66.7%
Q4 2022$1,851,886
+18.9%
63,5950.0%0.00%
+50.0%
Q3 2022$1,558,077
+686.9%
63,595
+269.4%
0.00%
Q1 2022$198,000
+15.1%
17,2160.0%0.00%
Q4 2021$172,000
-23.6%
17,216
-0.2%
0.00%
Q3 2021$225,000
-33.4%
17,2590.0%0.00%
-100.0%
Q2 2021$338,000
-0.9%
17,259
+7.7%
0.00%0.0%
Q1 2021$341,000
-22.3%
16,031
+8.6%
0.00%0.0%
Q4 2020$439,000
+66.9%
14,766
+21.8%
0.00%0.0%
Q3 2020$263,000
-2.6%
12,1260.0%0.00%0.0%
Q2 2020$270,000
+20.0%
12,126
-18.0%
0.00%0.0%
Q1 2020$225,000
-29.7%
14,796
+6.1%
0.00%0.0%
Q4 2019$320,00013,9500.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 735,000$13,112,4003.93%
NEA Management Company, LLC 2,909,956$51,913,6153.59%
Frazier Life Sciences Management, L.P. 2,164,739$38,618,9442.80%
RA Capital Management 5,516,067$98,406,6352.23%
Samsara BioCapital, LLC 345,293$6,160,0271.27%
Rock Springs Capital Management LP 1,597,123$28,492,6740.68%
Baker Brothers Advisors 6,498,267$115,929,0830.63%
HighVista Strategies LLC 35,478$632,9280.52%
Nan Fung Group Holdings Ltd 32,520$580,1570.40%
GREAT POINT PARTNERS LLC 97,544$1,740,1850.34%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders